MKS Instruments Announces First Quarter 2025 Earnings Conference Call ANDOVER, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release first quarter 2025 financial results after market close on Wednesday, May 7, 2025. A conference call with management will be held on Thursday, May 8, 2025 at 8:30 a.m. (Eastern Time). A live and archived webcast of the call can be accessed on the company’s website at , or by registering as a Participant by clicking . W...
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
LOS ANGELES--(BUSINESS WIRE)-- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on March 4, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of an inducement restricted stock unit award covering 3,500 shares of Puma common stock to one new non-executive employee. The award was granted under Puma’s 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awards to new employees of Puma. The restricted stock unit award vests over a three-year period, with one-t...
LOS ANGELES--(BUSINESS WIRE)-- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will provide an overview of Puma at 2:00 p.m. ET on Tuesday, March 11, at Barclays 27th Annual Global Healthcare Conference. The conference will be held at the Loews Miami Beach. A live webcast of the presentation will be available on the Puma Biotechnology website at . The presentation will be archived on the website and available for replay for 30 days. About Puma Biotechnology Puma Biotechnology, In...
LOS ANGELES--(BUSINESS WIRE)-- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will provide an overview of Puma at 2:00 p.m. ET on Tuesday, March 11, at Barclays 27th Annual Global Healthcare Conference. The conference will be held at the Loews Miami Beach. A live webcast of the presentation will be available on the Puma Biotechnology website at . The presentation will be archived on the website and available for replay for 30 days. About Puma Biotechnology Puma Biotechnology, In...
LOS ANGELES--(BUSINESS WIRE)-- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2024. Unless otherwise stated, all comparisons are for the fourth quarter and full year 2024 compared to the fourth quarter and full year 2023. Product revenue, net consists entirely of revenue from sales of NERLYNX®, Puma’s first commercial product. Product revenue, net for the fourth quarter of 2024 was $54.4 million, compared to $53.2 million in the fourth quarter of 2023. Product revenue, net for the full year ...
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
LOS ANGELES--(BUSINESS WIRE)-- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will provide an overview of Puma at 11:10 a.m. ET on Wednesday, March 5, at the TD Cowen 45th Annual Health Care Conference. The conference will be held March 3–5, 2025 at the Boston Marriott Copley Place in Boston. A live webcast of the presentation will be available on the Puma Biotechnology website at . The presentation will be archived on the website and available for replay for 30 days. About Pum...
MKS Instruments to Participate in Cantor Fitzgerald Global Technology Conference ANDOVER, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, announced today that John T.C. Lee, President and Chief Executive Officer, will participate in a fireside chat at Cantor Fitzgerald Global Technology Conference on Tuesday, March 11, 2025 at 1:00 p.m. EDT. A live webcast of the session will be available in the Investor Relations section of the company's website at and a replay of the event will be avail...
LOS ANGELES--(BUSINESS WIRE)-- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on Thursday, February 27, 2025, following the release of its fourth quarter and full year 2024 financial results. The call may be accessed by dialing 1-877-709-8150 (domestic) or 1-201-689-8354 (international). Please dial in at least 10 minutes in advance and inform the operator that you would like to join the “Puma Biotechnology Conference Call.” A live webcast of the conference call and presentation slides may be accessed on the Inve...
MKS Instruments Reports Fourth Quarter and Full-Year 2024 Financial Results Quarterly revenue of $935 million, above the midpoint of guidance Quarterly GAAP net income of $90 million and net income per diluted share of $1.33Quarterly Adjusted EBITDA of $237 million and Non-GAAP net earnings per diluted share of $2.15, above the midpoint of guidance ANDOVER, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today reported fourth quarter and full year 2024 financial results. “MKS delivered re...
MKS Instruments Declares Quarterly Cash Dividend ANDOVER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on March 7, 2025, to shareholders of record as of February 24, 2025. Future dividend declarations, as well as the record and payment dates for such dividends, are subject to the final determination of the Company's Board of Directors. About MKS InstrumentsMKS Instruments en...
LOS ANGELES--(BUSINESS WIRE)-- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on February 4, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 7,250 shares of Puma common stock to two new non-executive employees. The awards were granted under Puma’s 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awards to new employees of Puma. The restricted stock unit awards vest over a three-year period, with ...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
MKS Instruments Completes Repricing on its Secured Term Loan B USD and EUR Tranches and Makes a $100 Million Voluntary Prepayment on its Secured Term Loan B USD ANDOVER, Mass., Jan. 24, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, announced today that it successfully completed the repricing of its $2.5 billion and €0.6 billion secured tranche B term loans maturing in 2029. The repricing results in a reduction of the interest rate for the USD tranche B term loans from SOFR plus a margin of 225 basis poin...
MKS Instruments Showcases Customer-Focused Photonics Innovations at SPIE’s Photonics West 2025 MKS’ signature brands – Newport™, Ophir®, and Spectra-Physics® – continue commitment to innovation with leading-edge products ANDOVER, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”), a global provider of enabling technologies that transform our world, is committed to developing, delivering, and scaling innovative, customer-focused products and services for the Photonics Industry. The MKS brands of the Photonics Solutions Division – Newport™, Ophir®, and Sp...
MKS Instruments Announces Fourth Quarter & Full Year 2024 Earnings Conference Call ANDOVER, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release fourth quarter and full year 2024 financial results after market close on Wednesday, February 12, 2025. A conference call with management will be held on Thursday, February 13, 2025 at 8:30 a.m. (Eastern Time). A live and archived webcast of the call can be accessed on the company’s website at , or by regis...
Moody's Ratings (Moody's) upgraded the senior unsecured long-term ratings of Zoetis Inc. (Zoetis) to A3 from Baa1. At the same time, we affirmed Zoetis' Prime-2 commercial paper rating. In tandem with these actions, we revised the outlook to stable from positive. "The upgrade to A3 reflects Zoetis...
MKS Instruments Receives 2024 Supplier Excellence Award for Innovation from Onto Innovation Inc. ANDOVER, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”), a global provider of enabling technologies that transform our world, was the recipient of the 2024 Supplier Excellence Award for Innovation presented by Onto Innovation Inc. The award was presented to MKS at Onto Innovation’s first-ever conference of strategic suppliers held on December 4, 2024, in Santa Clara, California. “We are honored by this recognition from Onto Innovation, which underscores ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.